Cord blood-derived CAR-NK cells targeting CD19

CAR-NK cells (CD19-targeted) derived from cord blood · Second Affiliated Hospital, School of Medicine, Zhejiang University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cord blood-derived CAR-NK cells targeting CD19, covering 2025-08-15 to 2025-08-15. Get the full timeline:

Most recent: Clinical Trial Update: Cord Blood-derived CAR-NK Cells Targeting CD19 for Refractory/Relapsed Central Nervous System Lymphoma [Phase 1]